Ruxolitinib Cream Combined With Corticosteroids for Progressive Non-Segmental Vitiligo: A Multicenter Real-World Study

NCT07673640 · clinicaltrials.gov ↗

RECRUITING

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Segmental Vitiligo (NSV)

Interventions

DRUG: 1.5% Ruxolitinib Phosphate Cream (Opzelura)
DRUG: Corticosteroid Therapy

Sponsor

ShanShan Li